Evidence map›Paper›PMID 41372116›Full record

ArticleCell discovery2025

Author Correction: Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.

Kang He, Xue-Jing Zhu, Yao-Ping Shi, Wei-Jian Huang, Tai-Hua Yang, Zhi-Feng Xi, Qi-Gen Li, Han-Yong Sun, Li-Jun Qian, Xiao-Song Chen and 16 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Kang He *Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.ORCID http://orcid.org/0000-0003-4671-1337
Xue-Jing Zhu *Celliver Biotechnology Inc., Shanghai, China.
Yao-Ping Shi *Department of Interventional Oncology, Renji Hospital, School of Medicine, Jiao Tong University, Shanghai, China.
Wei-Jian Huang *Celliver Biotechnology Inc., Shanghai, China.
Tai-Hua Yang *Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhi-Feng XiDepartment of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Qi-Gen LiDepartment of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Han-Yong SunDepartment of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Li-Jun QianDepartment of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Xiao-Song ChenDepartment of Infectious Diseases, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Pei-Ying LiDepartment of Anesthesiology and Critical Care Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.ORCID http://orcid.org/0000-0002-5721-9914
Xu ZhouDepartment of Anesthesiology and Critical Care Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Gui-Ying GuCelliver Biotechnology Inc., Shanghai, China.
Fan LiCelliver Biotechnology Inc., Shanghai, China.
Wen-Ming LiuDepartment of Anesthesiology and Critical Care Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Cai-Yang ChenDepartment of Anesthesiology and Critical Care Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Jie ZhaoDepartment of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Hong-Ping WuDepartment of Clinical Laboratory, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Fang-Rong YanDepartment of Biostatistics, China Pharmaceutical University, Nanjing, Jiangsu, China.ORCID http://orcid.org/0000-0003-3347-5021
Michael OttDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Amar Deep SharmaDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0003-3599-2372
Hui LiuDepartment of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Wei-Feng YuDepartment of Anesthesiology and Critical Care Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. ywf808@yeah.net.ORCID http://orcid.org/0000-0003-1979-6304
Bo ZhaiDepartment of Interventional Oncology, Renji Hospital, School of Medicine, Jiao Tong University, Shanghai, China. zhaiboshi@sina.com.ORCID http://orcid.org/0000-0003-4337-7126
He-Xin YanCelliver Biotechnology Inc., Shanghai, China. hexinyw@163.com.ORCID http://orcid.org/0000-0001-8390-650X
Qiang XiaDepartment of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. xiaqiang@shsmu.edu.cn.ORCID http://orcid.org/0000-0001-9482-6951

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41372116
PMCPMC12695932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.